LSBCF (LakeShore Biopharma Co) Total Stockholders Equity: $68.94 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Total Stockholders Equity?

LakeShore Biopharma Co LSBCF Total Stockholders Equity is $68.94 Mil as of Mar. 2025.

LakeShore Biopharma Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $68.94 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. LakeShore Biopharma Co's Book Value per Share for the quarter that ended in Mar. 2025 was $3.32. The ratio of a company's debt over equity can be used to measure how leveraged this company is. LakeShore Biopharma Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.83.

LakeShore Biopharma Co  (OTCPK:LSBCF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

LakeShore Biopharma Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(68.938-0)/20.767
=3.32

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

LakeShore Biopharma Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(53.922 + 3.242) / 68.938
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Stockholders Equity Related Terms

LakeShore Biopharma Co Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Stockholders Equity Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Stockholders Equity
-78.16 -110.17 105.71 81.26 68.94

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 105.71 76.34 81.26 85.15 68.94
What does a Total Stockholders Equity of $68.94 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Total Stockholders Equity of $68.94 Mil as of Mar. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Stockholders Equity too high?
LakeShore Biopharma Co's current Total Stockholders Equity is $68.94 Mil.
How does LakeShore Biopharma Co's Total Stockholders Equity compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Stockholders Equity of $68.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Stockholders Equity is $68.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Stockholders Equity of $68.94 Mil. The current Total Stockholders Equity is $68.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Stockholders Equity is $68.94 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.